Rapid Micro Biosystems Inc - Ordinary Shares - Class A Share News
$0.66
4.90%
day before yesterday
Nasdaq,
Jun 28, 10:00 pm CET
Rapid Micro Biosystems Inc - Ordinary Shares - Class A Share News
Neutral
Seeking Alpha
●
about 2 months ago
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Michael Beaulieu - CFA Vice President, Investor Relations and Corporate Communications Robert Spignesi - President and CEO Sean Wirtjes - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Steven Mah - TD Cowen Operator Thank you for standing by. My name ...
Neutral
GlobeNewsWire
●
about 2 months ago
Reports first quarter 2024 total revenue of $5.6 million , representing growth of 11% compared to first quarter 2023
Neutral
GlobeNewsWire
●
2 months ago
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2024 financial results prior to the market open on Friday, May 3, 2024.
Neutral
GlobeNewsWire
●
3 months ago
Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application
Neutral
GlobeNewsWire
●
4 months ago
LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the virtual KeyBanc Life Sciences & MedTech Inves...
Neutral
GlobeNewsWire
●
4 months ago
LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that, effective March 4, 2024, the Compensation Committee of the Company's Board of Di...
Neutral
Seeking Alpha
●
4 months ago
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
Neutral
GlobeNewsWire
●
4 months ago
Reports fourth quarter 2023 total revenue of $6.3 million , representing 45% growth compared to fourth quarter 2022
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
